Do analysts rate COSM or MEDS?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cosmos Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Wellgistics Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media refer more to COSM or MEDS?

In the previous week, Cosmos Health had 1 more articles in the media than Wellgistics Health. MarketBeat recorded 3 mentions for Cosmos Health and 2 mentions for Wellgistics Health. Wellgistics Health's average media sentiment score of 0.28 beat Cosmos Health's score of 0.10 indicating that Wellgistics Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cosmos Health 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Wellgistics Health 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate YI or MEDS?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score 111 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Wellgistics Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better earnings and valuation, YI or MEDS?

111 has higher revenue and earnings than Wellgistics Health. 111 is trading at a lower price-to-earnings ratio than Wellgistics Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio 111 $10.48B 0.00 -$9.65M -$1.60 N/A Wellgistics Health $23.34M 0.46 -$101.28M -$46.13 N/A

Is YI or MEDS more profitable?

111 has a net margin of -1.01% compared to Wellgistics Health's net margin of -1,100.16%. Company Net Margins Return on Equity Return on Assets 111 -1.01% N/A -4.86% Wellgistics Health -1,100.16% N/A -171.81%

Does the media refer more to YI or MEDS?

In the previous week, 111 and 111 both had 2 articles in the media. 111's average media sentiment score of 0.33 beat Wellgistics Health's score of 0.28 indicating that 111 is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment 111 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Wellgistics Health 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer RDGT or MEDS?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ridgetech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Wellgistics Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable valuation and earnings, RDGT or MEDS?

Ridgetech has higher revenue and earnings than Wellgistics Health. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ridgetech $132.16M 0.02 -$1.25M N/A N/A Wellgistics Health $23.34M 0.46 -$101.28M -$46.13 N/A

Is RDGT or MEDS more profitable?

Ridgetech has a net margin of 0.00% compared to Wellgistics Health's net margin of -1,100.16%. Company Net Margins Return on Equity Return on Assets Ridgetech N/A N/A N/A Wellgistics Health -1,100.16% N/A -171.81%

Do analysts rate MEDS or HKPD?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Wellgistics Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Hong Kong Pharma Digital Technology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better valuation and earnings, MEDS or HKPD?

Hong Kong Pharma Digital Technology has lower revenue, but higher earnings than Wellgistics Health. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Wellgistics Health $23.34M 0.46 -$101.28M -$46.13 N/A Hong Kong Pharma Digital Technology $13.43M 0.13 -$1.14M N/A N/A

Is MEDS or HKPD more profitable?

Hong Kong Pharma Digital Technology has a net margin of 0.00% compared to Wellgistics Health's net margin of -1,100.16%. Company Net Margins Return on Equity Return on Assets Wellgistics Health -1,100.16% N/A -171.81% Hong Kong Pharma Digital Technology N/A N/A N/A

Do analysts rate MEDS or MCK?

McKesson has a consensus target price of $973.44, indicating a potential upside of 6.27%. Given McKesson's stronger consensus rating and higher probable upside, analysts plainly believe McKesson is more favorable than Wellgistics Health. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Wellgistics Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 McKesson 0 Sell rating(s) 4 Hold rating(s) 14 Buy rating(s) 0 Strong Buy rating(s) 2.78

Which has stronger earnings and valuation, MEDS or MCK?

McKesson has higher revenue and earnings than Wellgistics Health. Wellgistics Health is trading at a lower price-to-earnings ratio than McKesson, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Wellgistics Health $23.34M 0.46 -$101.28M -$46.13 N/A McKesson $410.98B 0.26 $4.76B $37.37 24.51

Does the media prefer MEDS or MCK?

In the previous week, McKesson had 21 more articles in the media than Wellgistics Health. MarketBeat recorded 23 mentions for McKesson and 2 mentions for Wellgistics Health. McKesson's average media sentiment score of 0.60 beat Wellgistics Health's score of 0.28 indicating that McKesson is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Wellgistics Health 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral McKesson 10 Very Positive mention(s) 6 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Wellgistics Health (MEDS) Competitors

$3.35 -0.33 (-8.97%)

As of 10/5/2026 04:00 PM Eastern

Compare

MEDS vs. COSM, YI, RDGT, HKPD, and MCK

Should you buy Wellgistics Health stock or one of its competitors? Wellgistics Health's main competitors and comparable companies include Cosmos Health (COSM), 111 (YI), Ridgetech (RDGT), Hong Kong Pharma Digital Technology (HKPD), and McKesson (MCK). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare distributors" industry.

How does Wellgistics Health compare to Cosmos Health?

Cosmos Health (NASDAQ:COSM) and Wellgistics Health (NASDAQ:MEDS) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, media sentiment, earnings, institutional ownership, risk, profitability and valuation.

12.6% of Cosmos Health shares are owned by institutional investors. Comparatively, 5.7% of Wellgistics Health shares are owned by institutional investors. 26.2% of Cosmos Health shares are owned by company insiders. Comparatively, 27.0% of Wellgistics Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Cosmos Health has a net margin of -33.08% compared to Wellgistics Health's net margin of -1,100.16%. Wellgistics Health's return on equity of 0.00% beat Cosmos Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cosmos Health	-33.08%	-56.88%	-18.03%
Wellgistics Health	-1,100.16%	N/A	-171.81%

In the previous week, Cosmos Health had 1 more articles in the media than Wellgistics Health. MarketBeat recorded 3 mentions for Cosmos Health and 2 mentions for Wellgistics Health. Wellgistics Health's average media sentiment score of 0.28 beat Cosmos Health's score of 0.10 indicating that Wellgistics Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cosmos Health	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Wellgistics Health	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Cosmos Health has a beta of 4.69, indicating that its share price is 369% more volatile than the broader market. Comparatively, Wellgistics Health has a beta of -3.51, indicating that its share price is 451% less volatile than the broader market.

Cosmos Health has higher revenue and earnings than Wellgistics Health. Cosmos Health is trading at a lower price-to-earnings ratio than Wellgistics Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cosmos Health	$73.73M	0.47	-$19.15M	-$0.64	N/A
Wellgistics Health	$23.34M	0.46	-$101.28M	-$46.13	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cosmos Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Wellgistics Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Cosmos Health beats Wellgistics Health on 9 of the 13 factors compared between the two stocks.

How does Wellgistics Health compare to 111?

111 (NASDAQ:YI) and Wellgistics Health (NASDAQ:MEDS) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, valuation, risk, institutional ownership, dividends, analyst recommendations and media sentiment.

111 has higher revenue and earnings than Wellgistics Health. 111 is trading at a lower price-to-earnings ratio than Wellgistics Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
111	$10.48B	0.00	-$9.65M	-$1.60	N/A
Wellgistics Health	$23.34M	0.46	-$101.28M	-$46.13	N/A

21.3% of 111 shares are held by institutional investors. Comparatively, 5.7% of Wellgistics Health shares are held by institutional investors. 43.9% of 111 shares are held by insiders. Comparatively, 27.0% of Wellgistics Health shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

111 has a net margin of -1.01% compared to Wellgistics Health's net margin of -1,100.16%.

Company	Net Margins	Return on Equity	Return on Assets
111	-1.01%	N/A	-4.86%
Wellgistics Health	-1,100.16%	N/A	-171.81%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
111	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Wellgistics Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, 111 and 111 both had 2 articles in the media. 111's average media sentiment score of 0.33 beat Wellgistics Health's score of 0.28 indicating that 111 is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
111	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Wellgistics Health	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

111 has a beta of 0.67, meaning that its stock price is 33% less volatile than the broader market. Comparatively, Wellgistics Health has a beta of -3.51, meaning that its stock price is 451% less volatile than the broader market.

Summary

111 beats Wellgistics Health on 9 of the 11 factors compared between the two stocks.

How does Wellgistics Health compare to Ridgetech?

Ridgetech (NASDAQ:RDGT) and Wellgistics Health (NASDAQ:MEDS) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, profitability, analyst recommendations, institutional ownership, earnings, valuation and dividends.

Ridgetech has a beta of -0.09, indicating that its stock price is 109% less volatile than the broader market. Comparatively, Wellgistics Health has a beta of -3.51, indicating that its stock price is 451% less volatile than the broader market.

In the previous week, Wellgistics Health had 2 more articles in the media than Ridgetech. MarketBeat recorded 2 mentions for Wellgistics Health and 0 mentions for Ridgetech. Ridgetech's average media sentiment score of 0.75 beat Wellgistics Health's score of 0.28 indicating that Ridgetech is being referred to more favorably in the media.

Company	Overall Sentiment
Ridgetech	Positive
Wellgistics Health	Neutral

Ridgetech has a net margin of 0.00% compared to Wellgistics Health's net margin of -1,100.16%.

Company	Net Margins	Return on Equity	Return on Assets
Ridgetech	N/A	N/A	N/A
Wellgistics Health	-1,100.16%	N/A	-171.81%

Ridgetech has higher revenue and earnings than Wellgistics Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ridgetech	$132.16M	0.02	-$1.25M	N/A	N/A
Wellgistics Health	$23.34M	0.46	-$101.28M	-$46.13	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ridgetech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Wellgistics Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

45.3% of Ridgetech shares are owned by institutional investors. Comparatively, 5.7% of Wellgistics Health shares are owned by institutional investors. 22.6% of Ridgetech shares are owned by company insiders. Comparatively, 27.0% of Wellgistics Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Ridgetech beats Wellgistics Health on 7 of the 10 factors compared between the two stocks.

How does Wellgistics Health compare to Hong Kong Pharma Digital Technology?

Wellgistics Health (NASDAQ:MEDS) and Hong Kong Pharma Digital Technology (NASDAQ:HKPD) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, media sentiment, profitability, institutional ownership, dividends, earnings, analyst recommendations and valuation.

Wellgistics Health has a beta of -3.51, meaning that its share price is 451% less volatile than the broader market. Comparatively, Hong Kong Pharma Digital Technology has a beta of 2.57, meaning that its share price is 157% more volatile than the broader market.

5.7% of Wellgistics Health shares are owned by institutional investors. 27.0% of Wellgistics Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Wellgistics Health had 2 more articles in the media than Hong Kong Pharma Digital Technology. MarketBeat recorded 2 mentions for Wellgistics Health and 0 mentions for Hong Kong Pharma Digital Technology. Wellgistics Health's average media sentiment score of 0.28 beat Hong Kong Pharma Digital Technology's score of 0.00 indicating that Wellgistics Health is being referred to more favorably in the media.

Company	Overall Sentiment
Wellgistics Health	Neutral
Hong Kong Pharma Digital Technology	Neutral

Hong Kong Pharma Digital Technology has a net margin of 0.00% compared to Wellgistics Health's net margin of -1,100.16%.

Company	Net Margins	Return on Equity	Return on Assets
Wellgistics Health	-1,100.16%	N/A	-171.81%
Hong Kong Pharma Digital Technology	N/A	N/A	N/A

Hong Kong Pharma Digital Technology has lower revenue, but higher earnings than Wellgistics Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Wellgistics Health	$23.34M	0.46	-$101.28M	-$46.13	N/A
Hong Kong Pharma Digital Technology	$13.43M	0.13	-$1.14M	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Wellgistics Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Hong Kong Pharma Digital Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Wellgistics Health beats Hong Kong Pharma Digital Technology on 6 of the 10 factors compared between the two stocks.

How does Wellgistics Health compare to McKesson?

Wellgistics Health (NASDAQ:MEDS) and McKesson (NYSE:MCK) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, profitability, earnings, valuation and media sentiment.

McKesson has a consensus target price of $973.44, indicating a potential upside of 6.27%. Given McKesson's stronger consensus rating and higher probable upside, analysts plainly believe McKesson is more favorable than Wellgistics Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Wellgistics Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
McKesson	0 Sell rating(s)	4 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.78

5.7% of Wellgistics Health shares are owned by institutional investors. Comparatively, 85.1% of McKesson shares are owned by institutional investors. 27.0% of Wellgistics Health shares are owned by company insiders. Comparatively, 0.1% of McKesson shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

McKesson has higher revenue and earnings than Wellgistics Health. Wellgistics Health is trading at a lower price-to-earnings ratio than McKesson, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Wellgistics Health	$23.34M	0.46	-$101.28M	-$46.13	N/A
McKesson	$410.98B	0.26	$4.76B	$37.37	24.51

Wellgistics Health has a beta of -3.51, suggesting that its share price is 451% less volatile than the broader market. Comparatively, McKesson has a beta of 0.3, suggesting that its share price is 70% less volatile than the broader market.

In the previous week, McKesson had 21 more articles in the media than Wellgistics Health. MarketBeat recorded 23 mentions for McKesson and 2 mentions for Wellgistics Health. McKesson's average media sentiment score of 0.60 beat Wellgistics Health's score of 0.28 indicating that McKesson is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Wellgistics Health	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
McKesson	10 Very Positive mention(s)	6 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

McKesson has a net margin of 1.12% compared to Wellgistics Health's net margin of -1,100.16%. Wellgistics Health's return on equity of 0.00% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Wellgistics Health	-1,100.16%	N/A	-171.81%
McKesson	1.12%	-253.21%	5.90%

Summary

McKesson beats Wellgistics Health on 13 of the 16 factors compared between the two stocks.

Get Wellgistics Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MEDS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MEDS vs. The Competition

Export

Metric	Wellgistics Health	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$11.77M	$9.68B	$7.14B	$13.26B
Dividend Yield	N/A	2.61%	2.53%	17.36%
P/E Ratio	-0.07	34.20	274.34	26.20
Price / Sales	0.46	4.83	629.40	95.18
Price / Cash	N/A	22.82	27.22	34.70
Price / Book	-0.48	5.20	11.23	6.40
Net Income	-$101.28M	$315.68M	$3.49B	$381.07M
7 Day Performance	-8.72%	-0.51%	-1.31%	-0.28%
1 Month Performance	265.72%	-2.62%	-5.97%	-4.51%
1 Year Performance	-90.65%	9.27%	7.26%	1.63%

Wellgistics Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MEDS Wellgistics Health	0.2466 of 5 stars	$3.35 -9.0%	N/A	-90.1%	$11.77M	$23.34M	N/A	31	Gap Down
COSM Cosmos Health	1.9797 of 5 stars	$0.35 flat	N/A	-68.0%	$35.38M	$65.27M	N/A	163
YI 111	0.4521 of 5 stars	$3.82 +6.0%	N/A	-30.0%	$33.53M	$1.80B	N/A	1,063
RDGT Ridgetech	0.8961 of 5 stars	$0.83 flat	N/A	-99.5%	$3.01M	$132.16M	N/A	980	Gap Up High Trading Volume
HKPD Hong Kong Pharma Digital Technology	0.5685 of 5 stars	$0.11 flat	N/A	-91.6%	$1.83M	$13.43M	N/A	11	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:MEDS) was last updated on 10/6/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Wellgistics Health (MEDS) Competitors

MEDS vs. COSM, YI, RDGT, HKPD, and MCK

How does Wellgistics Health compare to Cosmos Health?

Summary

How does Wellgistics Health compare to 111?

Summary

How does Wellgistics Health compare to Ridgetech?

Summary

How does Wellgistics Health compare to Hong Kong Pharma Digital Technology?

Summary

How does Wellgistics Health compare to McKesson?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MEDS vs. The Competition

Wellgistics Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Wellgistics Health (MEDS) Competitors

MEDS vs. COSM, YI, RDGT, HKPD, and MCK

How does Wellgistics Health compare to Cosmos Health?

Do institutionals and insiders believe in COSM or MEDS?

Is COSM or MEDS more profitable?

Does the media refer more to COSM or MEDS?

Which has more volatility & risk, COSM or MEDS?

Which has preferable valuation and earnings, COSM or MEDS?

Do analysts rate COSM or MEDS?

Summary

How does Wellgistics Health compare to 111?

Which has better earnings and valuation, YI or MEDS?

Do insiders and institutionals hold more shares of YI or MEDS?

Is YI or MEDS more profitable?

Do analysts rate YI or MEDS?

Does the media refer more to YI or MEDS?

Which has more risk and volatility, YI or MEDS?

Summary

How does Wellgistics Health compare to Ridgetech?

Which has more risk & volatility, RDGT or MEDS?

Does the media refer more to RDGT or MEDS?

Is RDGT or MEDS more profitable?

Which has preferable valuation and earnings, RDGT or MEDS?

Do analysts prefer RDGT or MEDS?

Do institutionals & insiders hold more shares of RDGT or MEDS?

Summary

How does Wellgistics Health compare to Hong Kong Pharma Digital Technology?

Which has more risk & volatility, MEDS or HKPD?

Do institutionals & insiders believe in MEDS or HKPD?

Does the media favor MEDS or HKPD?

Is MEDS or HKPD more profitable?

Which has better valuation and earnings, MEDS or HKPD?

Do analysts rate MEDS or HKPD?

Summary

How does Wellgistics Health compare to McKesson?

Do analysts rate MEDS or MCK?

Do insiders and institutionals have more ownership in MEDS or MCK?

Which has stronger earnings and valuation, MEDS or MCK?

Which has more risk and volatility, MEDS or MCK?

Does the media prefer MEDS or MCK?

Is MEDS or MCK more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MEDS vs. The Competition

Wellgistics Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools